Here are the latest quarterly results of NURECA. For more details, see the NURECA financial fact sheet and NURECA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 410 | 255 | 368 | 278 | 212 | 212 | 314 | 224 | |
Other income | Rs m | 17 | 12 | 19 | 19 | 21 | 27 | 32 | 59 | |
Turnover | Rs m | 428 | 267 | 387 | 297 | 234 | 239 | 346 | 283 | |
Expenses | Rs m | 438 | 313 | 417 | 287 | 247 | 241 | 300 | 266 | |
Gross profit | Rs m | -27 | -57 | -49 | -9 | -35 | -29 | 14 | -43 | |
Depreciation | Rs m | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
Interest | Rs m | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Profit before tax | Rs m | -19 | -53 | -37 | 3 | -20 | -9 | 39 | 9 | |
Tax | Rs m | -5 | -12 | -8 | -0 | -4 | -2 | 10 | 8 | |
Profit after tax | Rs m | -14 | -41 | -29 | 3 | -15 | -7 | 29 | 2 | |
Gross profit margin | % | -6.7 | -22.4 | -13.3 | -3.3 | -16.3 | -13.7 | 4.4 | -19.0 | |
Effective tax rate | % | 26.3 | 22.1 | 22.7 | -11.5 | 22.5 | 23.9 | 26.0 | 82.5 | |
Net profit margin | % | -3.4 | -16.2 | -7.9 | 1.1 | -7.2 | -3.3 | 9.2 | 0.7 | |
Diluted EPS | Rs | -1.4 | -4.1 | -2.9 | 0.3 | -1.5 | -0.7 | 2.9 | 0.2 | |
Diluted EPS (TTM) | Rs | 45.0 | 4.6 | -3.7 | -8.1 | -8.2 | -4.8 | 1.0 | 0.8 | |
Subscriber Feature |
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.